Glucocorticoids are known to be effective in the treatment of nasal polyps (NPs). To examine the mechanisms of their effect, we evaluated 1) the ability of glucocorticoids to induce the apoptosis of eosinophils and T lymphocytes in NPs, and 2) the ability of dexamethasone to down-regulate epithelial cell functions that relate to eosinophilic inflammation. In vitro and in vivo, glucocorticoids increased the apoptosis of both eosinophils and T lymphocytes in NPs. Dexamethasone inhibited the production of granulocyte-macrophage colony-stimulating factor (GM-CSF) from both NP epithelial cells that were unstimulated and NP epithelial cells that were stimulated with interleukin-4 or tumor necrosis factor a. These results suggest that the clinical efficacy of glucocorticoids on NPs may be due to 1) induction of apoptosis in both eosinophils and T lymphocytes that infiltrate NPs, and 2) down-regulation of epithelial GM-CSF production, which prolongs eosinophil survival.
KanaiNDenburgJJordanaMDolovichJ. Nasal polyp inflammation. Effect of topical nasal steroid. Am J Respir Crit Care Med1994; 150: 1094–100.
2.
ElovicAWongDTWellerPFMatossianKGalliSJ. Expression of transforming growth factors-alpha and beta 1 messenger RNA and product by eosinophils in nasal polyps. J Allergy Clin Immunol1994; 93: 864–9.
3.
StoopAEvan der HeijdenHABiewengaJvan der BaanS. Eosinophils in nasal polyps and nasal mucosa: An immunohistochemical study. J Allergy Clin Immunol1993; 91: 616–22.
4.
SimonHUYousefiSSchranzCSchapowalABachertCBlaserK. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol1997; 158: 3902–8.
5.
TaiPCSunLSpryCJ. Effects of IL-5, granulocyte/macrophage colony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophils in vitro. Clin Exp Immunol1991; 85: 312–6.
6.
HamilosDLLeungDYWoodR. Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. J Allergy Clin Immunol1995; 96: 537–44.
7.
PedersenCBMygindNSorensenHPrytzS. Long-term treatment of nasal polyps with beclomethasone dipropionate aerosol. II. Clinical results. Acta Otolaryngol (Stockh)1976; 82: 256–9.
8.
MeagherLCCousinJMSecklJRHaslettC. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol1996; 156: 4422–8.
9.
LanzaLScudelettiMPuppoF. Prednisone increases apoptosis in in vitro activated human peripheral blood T lymphocytes. Clin Exp Immunol1996; 103: 482–90.
10.
CoxGOhtoshiTVancheriC. Promotion of eosinophil survival by human bronchial epithelial cells and its modulation by steroids. Am J Respir Cell Mol Biol1991; 4: 525–31.
11.
XaubetAMullolJLopezE. Comparison of the role of nasal polyp and normal nasal mucosal epithelial cells on in vitro eosinophil survival. Mediation by GM-CSF and inhibition by dexamethasone. Clin Exp Allergy1994; 24: 307–17.
12.
ShirasakiHKanaizumiEWatanabeK. Tumor necrosis factor increases MUC1 mRNA in cultured human nasal epithelial cells. Acta Otolaryngol (Stockh)2003; 123: 524–31.
13.
FanGKItohTImanakaMFujiedaSTakenakaH. Eosinophilic apoptosis in sinus mucosa: Relationship to tissue eosinophilia and its resolution in allergic sinusitis. J Allergy Clin Immunol2000; 106: 551–8.
14.
DruilheAWallaertBTsicopoulosA. Apoptosis, proliferation, and expression of Bcl-2, Fas, and Fas ligand in bronchial biopsies from asthmatics. Am J Respir Cell Mol Biol1998; 19: 747–57.
15.
SaundersMWWheatleyAHGeorgeSJLaiTBirchallMA. Do corticosteroids induce apoptosis in nasal polyp inflammatory cells? In vivo and in vitro studies. Laryngoscope1999; 109: 785–90.
16.
AllenJSEismaRLeonardGKreutzerD. Interleukin-3 interleukin-5, and granulocyte-macrophage colony-stimulating factor expression in nasal polyps. Am J Otolaryngol1997; 18: 239–46.
17.
AdachiTMotojimaSHirataA. Eosinophil apoptosis caused by theophylline, glucocorticoids, and macrolides after stimulation with IL-5. J Allergy Clin Immunol1996; 98(suppl): S207–S215.
18.
RudackCBachertCStollW. Effect of prednisolone on cytokine synthesis in nasal polyps. J Interferon Cytokine Res1999; 19: 1031–5.
19.
CorriganCJHamidQNorthJ. Peripheral blood CD4 but not CD8 T-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: Effect of glucocorticoid therapy. Am J Respir Cell Mol Biol1995; 12: 567–78.
20.
VignolaAMChanezPChiapparaG. Evaluation of apoptosis of eosinophils, macrophages, and T lymphocytes in mucosal biopsy specimens of patients with asthma and chronic bronchitis. J Allergy Clin Immunol1999; 103: 563–73.
21.
HenrikssonGNorlanderTForsgrenJStiernaP. Effects of topical budesonide treatment on glucocorticoid receptor mRNA down-regulation and cytokine patterns in nasal polyps. Am J Rhinol2001; 15: 1–8.
22.
PaliogianniFRaptisAAhujaSSNajjarSMBoumpasDT. Negative transcriptional regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-1 and NF-AT. J Clin Invest1993; 91: 1481–9.
23.
Sanchez-SeguraABrievaJARodriguezC. T lymphocytes that infiltrate nasal polyps have a specialized phenotype and produce a mixed TH1/TH2 pattern of cytokines. J Allergy Clin Immunol1998; 102: 953–60.
24.
ShirasakiHWatanabeKKanaizumiE. Analysis of apoptotic cells in allergic and non-allergic nasal mucosa. Allergol Int2001; 50: 311–7.
TingsgaardPKLarsenPLBockTVejlsgaardLange GTosM. Expression of intercellular adhesion molecule–1 on the vascular endothelium in nasal polyps before, during and after topical glucocorticoid treatment. Acta Otolaryngol (Stockh)1998; 118: 404–8.
27.
JahnsenFLHayeRGranEBrandtzaegPJohansenFE. Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophilia. J Immunol1999; 163: 1545–51.
28.
SalviSSemperABlombergA. Interleukin-5 production by human airway epithelial cells. Am J Respir Cell Mol Biol1999; 20: 984–91.
29.
ReibmanJTalbotATHsuY. Regulation of expression of granulocyte-macrophage colony-stimulating factor in human bronchial epithelial cells: Roles of protein kinase C and mitogen-activated protein kinases. J Immunol2000; 165: 1618–25.
30.
NakamuraYAzumaMOkanoY. Upregulatory effects of interleukin-4 and interleukin-13 but not interleukin-10 on granulocyte/macrophage colony-stimulating factor production by human bronchial epithelial cells. Am J Respir Cell Mol Biol1996; 15: 680–7.
31.
FinottoSOhnoIMarshallJS. TNF-alpha production by eosinophils in upper airways inflammation (nasal polyposis). J Immunol1994; 153: 2278–89.
32.
NonakaMNonakaRWoolleyK. Distinct immunohistochemical localization of IL-4 in human inflamed airway tissues. IL-4 is localized to eosinophils in vivo and is released by peripheral blood eosinophils. J Immunol1995; 155: 3234–44.
33.
JanyBBetzRSchreckR. Activation of the transcription factor NF-kappa B in human tracheobronchial epithelial cells by inflammatory stimuli. Eur Respir J1995; 8: 387–91.
34.
MatsukuraSStellatoCPlittJR. Activation of eotaxin gene transcription by NF-kappa B and STAT6 in human airway epithelial cells. J Immunol1999; 163: 6876–83.
35.
RayAZhangDHRayP. Antagonism of nuclear factor-kappa B functions by steroid hormone receptors. Biochem Soc Trans1995; 23: 952–8.
36.
KimYKNakagawaNNakanoKSulakvelidzeIDolovichJDenburgJ. Stem cell factor in nasal polyposis and allergic rhinitis: Increased expression by structural cells is suppressed by in vivo topical corticosteroids. J Allergy Clin Immunol1997; 100: 389–99.
